Terms: = Endocrine gland cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Prognosis
16 results:
1. A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma.
Xu D; Lai Y; Liu H; Li H; Feng N; Liu Y; Gong C; Zhang Y; Zhou J; Shen Y
Transl Res; 2024 Feb; 264():76-84. PubMed ID: 37863284
[TBL] [Abstract] [Full Text] [Related]
2. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
[TBL] [Abstract] [Full Text] [Related]
3. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy.
Ju Y; Wang L; Cheng F; Huang F; Chen X; Song Q; Xiao J; Zhu X; Jia H
BMC Endocr Disord; 2023 Jan; 23(1):19. PubMed ID: 36670396
[TBL] [Abstract] [Full Text] [Related]
4. Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer.
Zhang W; Ling Y; Li Z; Peng X; Ren Y
Cancer Med; 2023 Apr; 12(8):10045-10061. PubMed ID: 36645174
[TBL] [Abstract] [Full Text] [Related]
5. HIST3H2A is a potential biomarker for pancreatic cancer: A study based on TCGA data.
Zhao M; Dai R
Medicine (Baltimore); 2021 Nov; 100(46):e27598. PubMed ID: 34797282
[TBL] [Abstract] [Full Text] [Related]
6. N6-Methyladenosine-Related RNA Signature Predicting the prognosis of Ovarian cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract] [Full Text] [Related]
8. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm.
Mungo B; Croce C; Oba A; Ahrendt S; Gleisner A; Friedman C; Schulick RD; Del Chiaro M
Ann Surg Oncol; 2021 Mar; 28(3):1533-1542. PubMed ID: 32743713
[TBL] [Abstract] [Full Text] [Related]
9. Older patients with differentiated thyroid cancer exhibit more aggressive pathological characteristics than younger patients.
Johar J; Britton H; Wiseman SM
Can J Surg; 2020 Feb; 63(1):E69-E70. PubMed ID: 32031767
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis of chyle leakage after central lymph node dissection for thyroid carcinoma].
Feng JL; Zhou QY; Chen J; Wang JD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):597-600. PubMed ID: 31434373
[No Abstract] [Full Text] [Related]
11. Prognostic values of common clinical parameters in advanced pancreatic ductal adenocarcinoma: a large multicenter cohort study of ten years.
Zhang C; Dong S; Wang L; Yu S; Zheng Y; Geng Y; Shen X; Ying H; Guo Y; Yu J; Deng Q; Meng Z; Li Z; Chen H; Shen Y; Chen Q
Discov Med; 2018 Mar; 25(137):91-98. PubMed ID: 29641971
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Value of Extranodal Extension in Thyroid cancer: A Meta-Analysis.
Suh S; Pak K; Seok JW; Kim IJ
Yonsei Med J; 2016 Nov; 57(6):1324-8. PubMed ID: 27593858
[TBL] [Abstract] [Full Text] [Related]
13. Improved Survival from Ovarian cancer in Patients Treated in Phase III Trial Active cancer Centres in the UK.
Khoja L; Nolan K; Mekki R; Milani A; Mescallado N; Ashcroft L; Hasan J; Edmondson R; Winter-Roach B; Kitchener HC; Mould T; Hutson R; Hall G; Clamp AR; Perren T; Ledermann J; Jayson GC
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):760-765. PubMed ID: 27401967
[TBL] [Abstract] [Full Text] [Related]
14. False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature.
Ballieux BE; Weijl NI; Gelderblom H; van Pelt J; Osanto S
Oncologist; 2008 Nov; 13(11):1149-54. PubMed ID: 18984875
[TBL] [Abstract] [Full Text] [Related]
15. Primary plasmacytoma of the testis. Case report and review of the literature.
Fischer C; Terpe HJ; Weidner W; Schulz A
Urol Int; 1996; 56(4):263-5. PubMed ID: 8776829
[TBL] [Abstract] [Full Text] [Related]
16. [Multiple extra-bone sites of Kahler's disease].
Hauteville D; Mayan B; Verdier M; Levot J; Bussière H; Jaubert D
Ann Med Interne (Paris); 1986; 137(7):548-51. PubMed ID: 3813295
[TBL] [Abstract] [Full Text] [Related]
